Rare Diseases
Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
Our Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsCase Study
Understand the regulatory environment, treatment pathways and patient journey for rare diseases in targeted geographies
Jan 30, 2023
The treatment for rare diseases continue to grow and come into focus, understanding patient pathways and the current treatment landscape are key to strengthening patient access.
The case study shows how an established biopharmaceutical company commercialized their Neurology rare disease asset in Asia Pacific by developing a deeper understanding of the market dynamics in targeted markets and optimizing its go-to-market model.
IQVIA conducted a pre-launch study and helped the client generate key insights for launch optimization and devise a strategic GTM plan. Discover how you can identify new opportunities to drive a successful product launch and impact the patient journey.
Related solutions
Therapeutic & Specialty Expertise
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.